Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thromboembolism 1Pulmonary Embolism 1Pancreatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Rivaroxaban 2apixaban 1Tinzaparin 1Laparoscopy 1Imaging, Three-Dimensional 1Hospitals 1Heparin, Low-Molecular-Weight 1Fluorodeoxyglucose F18 1Enoxaparin 1Dabigatran 1Conversion to Open Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Venous Thrombosis × Tinzaparin × Clear all
NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡